DK418489A - Anvendelse af purinderivater til fremstilling af antivirale farmaceutika - Google Patents

Anvendelse af purinderivater til fremstilling af antivirale farmaceutika

Info

Publication number
DK418489A
DK418489A DK418489A DK418489A DK418489A DK 418489 A DK418489 A DK 418489A DK 418489 A DK418489 A DK 418489A DK 418489 A DK418489 A DK 418489A DK 418489 A DK418489 A DK 418489A
Authority
DK
Denmark
Prior art keywords
purinder
derivatives
preparation
antiviral pharmaceuticals
antiviral
Prior art date
Application number
DK418489A
Other languages
English (en)
Other versions
DK418489D0 (da
Inventor
Patrick T Prendergast
Original Assignee
Patrick T Prendergast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patrick T Prendergast filed Critical Patrick T Prendergast
Publication of DK418489D0 publication Critical patent/DK418489D0/da
Publication of DK418489A publication Critical patent/DK418489A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK418489A 1988-08-25 1989-08-24 Anvendelse af purinderivater til fremstilling af antivirale farmaceutika DK418489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE882585A IE882585L (en) 1988-08-25 1988-08-25 Viral treatment system

Publications (2)

Publication Number Publication Date
DK418489D0 DK418489D0 (da) 1989-08-24
DK418489A true DK418489A (da) 1990-02-26

Family

ID=11035556

Family Applications (1)

Application Number Title Priority Date Filing Date
DK418489A DK418489A (da) 1988-08-25 1989-08-24 Anvendelse af purinderivater til fremstilling af antivirale farmaceutika

Country Status (12)

Country Link
US (1) US5681831A (da)
EP (1) EP0355825A3 (da)
JP (1) JP3237836B2 (da)
KR (1) KR900002786A (da)
AU (1) AU636574B2 (da)
CA (1) CA1339854C (da)
DK (1) DK418489A (da)
FI (1) FI893948L (da)
IE (1) IE882585L (da)
IL (1) IL91415A (da)
OA (1) OA09427A (da)
ZA (1) ZA896450B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
AU7920491A (en) * 1990-06-21 1992-01-02 Patrick T. Prendergast Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
KR20000005539A (ko) * 1996-04-17 2000-01-25 패트릭 티. 프렌더가스트 Dhea복합요법
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
FR2759091B1 (fr) * 1997-02-06 1999-03-19 Expertises Ind Et Procede biologique d'obtention de nouveaux derives de l'adenosine et les compositions pharmaceutiques qui les contiennent
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
US6800616B2 (en) 1998-02-26 2004-10-05 Supergen, Inc. Treatment of HIV infections
CA2552596A1 (en) * 2005-08-09 2007-02-09 Solvay Pharmaceuticals B.V. Methods and systems for determining mid-value titers
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
US3758684A (en) * 1971-09-07 1973-09-11 Burroughs Wellcome Co Treating dna virus infections with amino purine derivatives
US3966916A (en) * 1972-09-09 1976-06-29 Boehringer Mannheim G.M.B.H. N(6)-disubstituted adenoisine compounds and therapeutic compositions
US4016262A (en) * 1973-08-01 1977-04-05 Boehringer Mannheim G.M.B.H. Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
US4007186A (en) * 1974-09-20 1977-02-08 Emanuel Carl F Process for preparing uric acid
JPS5712999A (en) * 1980-06-25 1982-01-22 Chiyokichi Iizuka Antibiral agent and its preparation
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US5093318A (en) * 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
US4687733A (en) * 1984-01-30 1987-08-18 Ohio State University Early cancer detection method
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
JP2930589B2 (ja) * 1986-10-06 1999-08-03 ザ ユニバーシィティ オブ バージニア アルミニ パテンツ ファンデーション 外科手術中における改善された心臓保護のためのアデノシン，ヒポキサンチン及びリボース含有溶液の使用
US4843066A (en) * 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
PT86660B (pt) * 1987-02-04 1992-02-28 Ciba Geigy Ag Processo para a preparacao de derivados de adenosina-5'-carboxamida
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
KR0141684B1 (ko) * 1988-06-09 1998-06-01 로오렌트 제이 레밀러드 2`,5`-올리고 아데닐레이트 유도체의 치료학적 이용
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections

Also Published As

Publication number Publication date
IL91415A0 (en) 1990-04-29
FI893948A7 (fi) 1990-02-26
IL91415A (en) 1995-08-31
IE882585L (en) 1990-02-25
CA1339854C (en) 1998-05-05
JPH02237996A (ja) 1990-09-20
US5681831A (en) 1997-10-28
FI893948A0 (fi) 1989-08-23
EP0355825A2 (en) 1990-02-28
AU4025689A (en) 1990-03-01
ZA896450B (en) 1991-04-24
EP0355825A3 (en) 1991-12-27
DK418489D0 (da) 1989-08-24
JP3237836B2 (ja) 2001-12-10
AU636574B2 (en) 1993-05-06
KR900002786A (ko) 1990-03-23
FI893948L (fi) 1990-02-26
OA09427A (en) 1992-10-15

Similar Documents

Publication Publication Date Title
DK230789A (da) Fremgangsmaade til fremstilling af cytidinderivater
DK404187D0 (da) Fremgangsmaade til fremstilling af thiazolderivater
DK418489A (da) Anvendelse af purinderivater til fremstilling af antivirale farmaceutika
DK612789D0 (da) Fremgangsmaade til fremstilling af pyridinderivater
DK250689A (da) Fremgangsmaade til fremstilling af napthalenderivater
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK30489A (da) Fremgangsmaade til fremstilling af pyranderivater
DK516286D0 (da) Fremgangsmaade til fremstilling af oxazolderivater
DK115291D0 (da) Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater
DK104389D0 (da) Anvendelse af imidazolderivater
DK514785A (da) Fremgangsmaade til fremstilling af derivater af alkoholer
DK455889D0 (da) Fremgangsmaade til fremstilling af kulhydratderivater
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK560989A (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
DK113189D0 (da) Fremgangsmaade til fremstilling af pyridinderivater
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK293589A (da) Fremgangsmaade til fremstiling af lactolderivater
DK229789A (da) Farmaceutiske oploesninger af triamteren
DK599689D0 (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
FI895572A7 (fi) Virusvastaisia yhdisteitä
DK171089D0 (da) Anvendelse af tetrazolderivater til fremstilling af laegemidler
DK326789D0 (da) Fremstilling af homonojirimycin-derivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment